Trevi Therapeutics (TRVI) Ownership - Who Owns Trevi Therapeutics?

589 Followers

Trevi Therapeutics (TRVI) Ownership Overview

1.51% Insiders

14.44% Mutual Funds

57.40% Other Institutional Investors

9.77% ETFs

16.88% Public Companies and

Individual Investors

The ownership structure of Trevi Therapeutics (TRVI) stock is a mix of institutional, retail, and individual investors. Approximately 81.61% of the company’s stock is owned by Institutional Investors, 1.51% is owned by Insiders, and 16.88% is owned by Public Companies and Individual Investors.

The ownership structure of Trevi Therapeutics (TRVI) stock is a mix of institutional, retail, and individual investors. Approximately 71.84% of the company’s stock is owned by Institutional Investors, 1.51% is owned by Insiders, and 9.77% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2025	Wexford Capital Lp	xxxxxxxxxxxxx	$1027065
Dec 31, 2025	Woodline Partners Lp	xxxxxxxxxxxxx	$12523530
Dec 31, 2025	Viking Global Investors Lp	xxxxxxxxxxxxx	$40047022

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	5,524,042	Institution	4.31%	59,107,249
	4,763,562	Institution	3.71%	50,970,113
	4,550,282	Institution	3.55%	48,688,017
Andreas Halvorsen	3,198,644	Institution	2.49%	34,225,491
	2,699,885	Institution	2.11%	28,888,770
	2,644,973	Institution	2.06%	28,301,211
	1,950,673	Institution	1.52%	20,872,201
	1,194,955	Institution	0.93%	12,786,019
Michael Rockefeller	1,000,282	Institution	0.78%	10,703,017
	956,910	Institution	0.75%	10,238,937

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
4,550,282	Institution	3.55%	48,688,017
2,699,885	Institution	2.11%	28,888,770
2,644,973	Institution	2.06%	28,301,211
1,950,673	Institution	1.52%	20,872,201
1,194,955	Institution	0.93%	12,786,019
956,910	Institution	0.75%	10,238,937
858,056	Institution	0.67%	9,181,199
763,568	Institution	0.60%	8,170,178
511,616	Institution	0.40%	5,474,291
454,246	Institution	0.35%	4,860,432

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	3,424,263	Institution	2.67%	40,817,215
iShares Russell 2000 ETF	2,238,419	Institution	1.74%	23,951,083
Vanguard Extended Market ETF	1,135,948	Institution	0.88%	13,540,500
iShares Russell 2000 Growth ETF	760,973	Institution	0.59%	8,142,411
iShares Biotechnology ETF	615,406	Institution	0.48%	6,584,844
Schwab U.S. Small-Cap ETF	508,510	Institution	0.40%	5,435,972
Vanguard Russell 2000 ETF	449,930	Institution	0.35%	5,363,166
SPDR S&P Pharmaceuticals ETF	435,080	Institution	0.34%	4,651,005
iShares U.S. Pharmaceuticals ETF	275,738	Institution	0.21%	2,950,397
Vanguard Health Care ETF	256,138	Institution	0.20%	3,053,165

FAQ

Who Owns Trevi Therapeutics Inc (TRVI)?

According to the latest TipRanks data, approximately 57.40% of the company's stock is held by institutional investors, 1.51% is held by insiders, and 16.88% is held by retail investors.

What percentage of Trevi Therapeutics Inc (TRVI) stock is held by institutional investors?

According to the latest TipRanks data, approximately 57.40% of Trevi Therapeutics Inc (TRVI) stock is held by institutional investors.

What percentage of Trevi Therapeutics Inc (TRVI) stock is held by retail investors?

According to the latest TipRanks data, approximately 16.88% of Trevi Therapeutics Inc (TRVI) stock is held by retail investors.

Who owns the most shares of Trevi Therapeutics Inc (TRVI)?

Vanguard owns the most shares of Trevi Therapeutics Inc (TRVI).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.